Table 1.
Patient Characteristics
| IMRT % (n = 75) | Control % (n = 87) | |
| Male (n) | 72 | 64 |
| Female (n) | 28 | 36 |
| Mean dose primary tumour | 69 Gy | 70 Gy |
| Mean age start RT | 59 yrs | 59 yrs |
| Mean interval between RT and Questionnaire | 2.3 yrs | 2.9 yrs |
| Tumour Site | ||
| Hypopharynx | 9 | 9 |
| Larynx | 31 | 31 |
| Nasopharynx | 7 | 6 |
| Oral cavity | 7 | 8 |
| Oropharynx | 37 | 45 |
| Thyroid | 7 | 0 |
| Other | 3 | 1 |
| T-stage | ||
| T1 | 16 | 5 |
| T2 | 37 | 27 |
| T3 | 25 | 33 |
| T4 | 22 | 35 |
| N-stage | ||
| N0 | 50 | 39 |
| N1 | 15 | 13 |
| N2 | 36 | 48 |
| Larynx | ||
| T1-2 (n) | 18 | 15 |
| T3-4 (n) | 5 | 12 |
| Oropharynx | ||
| T1-2 (n) | 10 | 5 |
| T3-4 (n) | 14 | 27 |
| Concommittant chemotherapy | 39 | 53 |
| Surgery | 24 | 15 |
| Gastrostomy | 3 | 6 |
| Xerostomia related medication | 17 | 20 |